择期单或双节段腰椎融合术关键风险因素:高医疗风险与大麻使用者的影响
这项回顾性病例对照研究纳入575例35至80岁择期单或双节段腰椎融合患者,按术前风险分类和大麻使用分为四组。高医疗风险合并大麻使用者相比正常风险非使用者,阿片类药物使用高两倍、住院时间更长、手术部位感染率更高。大麻使用与手术部位感染率升高相关,烟草使用和精神疾病与急诊就诊和再入院相关,酒精使用和术前疼痛与重返手术室相关。
要点
- 高医疗风险合并大麻使用者阿片类药物使用高两倍、住院时间更长、手术部位感染率更高。
- 大麻使用与手术部位感染率升高相关,应纳入术前筛查。
- 烟草使用和精神疾病与急诊就诊和再入院相关,酒精使用和术前疼痛与重返手术室相关。
核心结论
- 大麻使用与不良脊柱融合结局相关,应作为术前筛查项目之一。
- 术前筛查可识别可能从术前优化和术后随访中获益的患者。
研究设计与样本
- 回顾性病例对照研究,纳入2022年1月至2025年5月期间575例35至80岁择期单或双节段腰椎融合患者。
- 按术前风险分类和大麻使用分为高医疗风险合并大麻使用者(HR-C,30例)、高医疗风险非使用者(HR,142例)、正常风险合并大麻使用者(NR-C,101例)、正常风险非使用者(NR,433例)。
主要发现
- HR-C患者相比NR非使用者,阿片类药物使用高两倍(P<0.001)、住院时间更长(P<0.001)、手术部位感染发生率更高(P<0.01)。
- 大麻使用与手术部位感染率升高相关。
- 烟草使用和精神疾病与急诊就诊和再入院相关。
- 酒精使用和术前疼痛与重返手术室相关。
临床怎么用
- 术前筛查应包含大麻使用、酒精使用、烟草使用和精神健康状况。
- 根据筛查结果对患者进行术前优化和术后随访,采用以患者为中心的针对性干预。
局限性
- 证据等级为III级,研究设计为回顾性病例对照研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: Retrospective case-control study. OBJECTIVES: The goal of this study was to identify key risk factors that were associated with 90-day complication rates, and 12-month recovery metrics following an elective single or 2-level lumbar fusion. SUMMARY OF BACKGROUND DATA: Preoperative screening for risk factors associated with poor outcomes is common in elective surgeries. Recent changes in legal status of cannabis has led to questions concerning the impact of cannabis use on postoperative recovery, complications, and pain management in patients undergoing elective lumbar fusions. METHODS: This retrospective study included patients ages 35 to 80 who underwent elective single- or two-level lumbar fusions between January 2022 and May 2025. Patients were classified as either high-risk or normal risk during their preoperative optimization visit. Four groups were created based on risk classification and cannabis use: high-risk cannabis users (HR-C), high-risk non-users (HR), normal risk cannabis users (NR-C), and normal risk non-users (NR). Differences were compared using Chi-squared tests and ANOVAs. Regression analyses identified preoperative metrics associated with poor outcomes. RESULTS: A total of 575 patients (142 HR, 30 HR-C, 433 NR, 101 NR-C) were included. HR-C patients showed two-fold higher opioid use ( P <0.001), longer length of stay ( P <0.001), and higher incidents of surgical site infections compared to NR- patients ( P <0.01). Cannabis use was associated with increased SSI rates, while tobacco use and mental illness were associated with emergency department utilization and readmissions, and alcohol use and preoperative pain were associated with return to the OR. CONCLUSIONS: This study identifies specific risk factors in patients with poor outcomes. Cannabis use was associated with adverse spinal fusion outcomes and should be included as a preoperative screen, with others such as alcohol and tobacco use, and mental health. Screening can determine which patients may benefit from preoperative optimization and postoperative follow-up using patient-centered targeted interventions. LEVEL OF EVIDENCE: III.
引用
- Kwaczala AT, Solomito MJ, McCracken C, et al. Identifying Key Risk Factors in Elective 1 or 2 Level Lumbar Spine Fusion Patients: A Focus on Patients Classified High Medical Risk who are Cannabis Users. Spine (Phila Pa 1976). 2026. PMID: 41812686. doi:10.1097/BRS.0000000000005672
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。